Dottikon Boosts Swiss API Capacities

Swiss fine chemical company Dottikon is investing more than 100 million Swiss francs ($101 million) at its site in Aargau to add chemical process development and production capacities for active pharmaceutical ingredients (APIs).

Multi-tonne API drying facilities will go into operation in the fourth quarter of 2016, while additional multi-purpose production capacities for sophisticated chemistry will become operational in the first half of 2017.

In addition, Dottikon will build a new laboratory and office building, which will be ready in 2018.

The company specializing in hazardous reactions, said it is positioning itself as a strategic development and manufacturing partner.

The company added 45 new jobs in the 2015-2016 financial year, 90% of them in chemical production. Dottikon said it expects to create a similar amount of new jobs in the coming business year.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.